Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits Tonya S. OrchardMonica M. Gaudier-DiazA. Courtney DeVries Review 08 December 2016 Pages: 391 - 398
Aryl hydrocarbon receptor induced intratumoral aromatase in breast cancer Ryoko SaitoYasuhiro MikiHironobu Sasano Preclinical Study 30 November 2016 Pages: 399 - 407
Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status Yul Ri ChungHyun Jeong KimSo Yeon Park Preclinical Study 02 December 2016 Pages: 409 - 420
Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer Michel van GelderAriane VancléeGerard M. Bos Preclinical Study Open access 03 December 2016 Pages: 421 - 433
Estimating the OncotypeDX score: validation of an inexpensive estimation tool Anne A. EatonCatherine E. PesceMahmoud El-Tamer Clinical trial 07 December 2016 Pages: 435 - 441
Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure? Kyeong Eun UhmJi Sung YooJi Hye Hwang Clinical trial 08 December 2016 Pages: 443 - 452
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer Jason D. RobargeZereunesay DestaN. Lynn Henry Clinical trial 09 December 2016 Pages: 453 - 461
Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients J. ShiaoK. M. ThomasD. W. Nathan Kim Clinical trial 22 December 2016 Pages: 463 - 471
Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial Daigo YamamotoNobuaki SatoKatsumasa Kuroi Clinical trial 22 December 2016 Pages: 473 - 482
Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply? V. HabrakenT. J. A. van NijnattenM. L. Smidt Epidemiology Open access 03 December 2016 Pages: 483 - 489
Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians Foluso O. AdemuyiwaYu TaoCynthia X. Ma Epidemiology 03 December 2016 Pages: 491 - 499
Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis Song YaoYali ZhangMarilyn L. Kwan Epidemiology 03 December 2016 Pages: 501 - 513
Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer Shuling LiJiannong LiuAllan J. Collins Epidemiology 08 December 2016 Pages: 515 - 524
The impact of doctor–patient communication on patients’ perceptions of their risk of breast cancer recurrence Nancy K. JanzYun LiSarah T. Hawley Epidemiology 09 December 2016 Pages: 525 - 535
Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis Bernardo Amadeo LeoneCarlos Teodoro VallejoJosé Pablo Leone Epidemiology 14 December 2016 Pages: 537 - 548
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed Wendie D. den BrokCaroline H. SpeersCaroline A. Lohrisch Epidemiology 20 December 2016 Pages: 549 - 556
Recurrence risk perception and quality of life following treatment of breast cancer Sarah T. HawleyNancy K. JanzSteven J. Katz Epidemiology 21 December 2016 Pages: 557 - 565
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome A. H. M. de Vries SchultinkX. AlexiJ. H. Beijnen Epidemiology 22 December 2016 Pages: 567 - 574
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results Mary PritzlaffPia SummerourHolly LaDuca Epidemiology Open access 22 December 2016 Pages: 575 - 586
The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients Yun LiAllison W. KurianTimothy P. Hofer Epidemiology 23 December 2016 Pages: 587 - 595
Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene A. Tavera-TapiaL. Pérez-CaborneroA. Osorio Brief Report 02 December 2016 Pages: 597 - 604
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration Gloria BertoliClaudia CavaIsabella Castiglioni Brief Report Open access 20 December 2016 Pages: 605 - 616
The effects of laterality in stage IV breast cancer patients at initial diagnosis; much work is needed! Kadri Altundag Letter to the Editor 06 January 2017 Pages: 617 - 617
Breast cancer is a systemic disease rather than an anatomical process Bernardo Amadeo LeoneJulieta LeoneJosé Pablo Leone Rebuttal Letter 09 January 2017 Pages: 619 - 619